Subhasis Barik

Subhasis Barik

Auto-generated profile, based on publicly available information

Subhasis Barik

Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, MO 65212

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SBSubhasis Barik
Subhasis Barik
Saptak BanerjeeSaptak Banerjee
Saptak Banerjee
AMAtanu Mallick
Atanu Mallick
KGKuntal Kanti Goswami
Kuntal Kanti Goswami
SRSoumyabrata Roy
Soumyabrata Roy
RBRathindranath Baral
Rathindranath Baral
We have observed restriction of the murine sarcoma growth by therapeutic intervention of neem leaf glycoprotein (NLGP). In order to evaluate the mechanism of tumor growth restriction, here, we have analyzed tumor microenvironment (TME) from sarcoma bearing mice with NLGP therapy (NLGP-TME, in comparison to PBS-TME). Analysis of cytokine milieu within TME revealed IL-10, TGFβ, IL-6 rich type 2 characters was switched to type 1 microenvironment with dominance of IFNγ secretion within NLGP-TME. Proportion of CD8 + T cells was increased within NLGP-TME and these T cells were protected from TME-induced anergy by NLGP, as indicated by higher expression of p NFAT and inhibit related downstream signaling. Moreover, low expression of FasR + cells within CD8 + T cell population denotes prevention from activation induced cell death. Using CFSE as a probe, better migration of T cells was noted within TME from NLGP treated mice than PBS cohort. CD8 + T cells isolated from NLGP-TME exhibited greater cytotoxicity to sarcoma cells in vitro and these cells show higher expression of cytotoxicity related molecules, perforin and granzyme B. Adoptive transfer of NLGP-TME exposed T cells, but not PBS-TME exposed cells in mice, is able to significantly inhibit the growth of sarcoma in vivo . Such tumor growth inhibition by NLGP-TME exposed T cells was not observed when mice were depleted for CD8 + T cells. Accumulated evidences strongly suggest NLGP mediated normalization of TME allows T cells to perform optimally to inhibit the tumor growth.

10 March 2023 in International Journal of Information Technology
Verified
Journal Article
Closed access
PDF file
SDSayantan Dass
Sayantan Dass
SMSujoy Mistry
Sujoy Mistry
PSPradyut Sarkar
Pradyut Sarkar
SBSubhasis Barik
Subhasis Barik
University of the West ScotlandUniversity of the West Scotland
University of the West Scotland

15 November 2018 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SBSubhasis Barik
Subhasis Barik
ACAlexis N. Cattin-Roy
Alexis N. Cattin-Roy
MMMindy M. Miller
Mindy M. Miller
TUTobechukwu K. Ukah
Tobechukwu K. Ukah
HZHabib Zaghouani
Habib Zaghouani
Recently we reported that IL-4 and IL-13 signaling in murine early thymic progenitors (ETPs) expressing the heteroreceptor (HR) comprising IL-4 receptor α (IL-4Rα) and IL-13 receptor α 1 (IL-13Rα1) activate STAT6 and inhibit ETP maturation potential toward T cells. In this study, we asked whether IL-4 and IL-13 signaling through the HR mobilizes other STAT molecules to shape ETP fate decision. The findings indicate that HR+ ETPs undergoing cytokine signaling display increased STAT1, but not STAT3, phosphorylation in addition to STAT6 activation. In parallel, the ETPs had a STAT1-dependent heightened expression of IRF-8, a transcription factor essential for development of CD8α+ dendritic cells (DCs). Interestingly, STAT1 phosphorylation and IRF-8 upregulation, which are independent of STAT6 activation, guided ETP maturation toward myeloid cells with a CD8α+ DC phenotype. Furthermore, these CD8α+ DCs display a thymic resident phenotype, as they did not express SIRPα, a molecule presumed to be involved in cell migration. These findings suggest that IL-4 and IL-13 cytokine-induced HR signaling provides a double-edged sword that simultaneously blocks T cell lineage potential but advances myeloid maturation that could impact T cell selection and central tolerance.

11 September 2020 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SBSubhasis Barik
Subhasis Barik
ACAlexis N. Cattin-Roy
Alexis N. Cattin-Roy
TUTobechukwu K. Ukah
Tobechukwu K. Ukah
MMMindy M. Miller
Mindy M. Miller
ETEmma Teixeiro
Emma Teixeiro
HZHabib Zaghouani
Habib Zaghouani
Early thymic progenitors (ETPs) are bone marrow–derived hematopoietic stem cells that remain multipotent and give rise to a variety of lineage-specific cells. Recently, we discovered a subset of murine ETPs that expresses the IL-4Rα/IL-13Rα1 heteroreceptor (HR) and commits only to the myeloid lineage. This is because IL-4/IL-13 signaling through the HR inhibits their T cell potential and enacts commitment of HR+ETPs to thymic resident CD11c+CD8α+ dendritic cells (DCs). In this study, we discovered that HR+-ETP–derived DCs function as APCs in the thymus and promote deletion of myelin-reactive T cells. Furthermore, this negative T cell selection function of HR+-ETP–derived DCs sustains protection against experimental allergic encephalomyelitis, a mouse model for human multiple sclerosis. These findings, while shedding light on the intricacies underlying ETP lineage commitment, reveal a novel, to our knowledge, function by which IL-4 and IL-13 cytokines condition thymic microenvironment to rheostat T cell selection and fine-tune central tolerance.

21 October 2026 in Developmental Biology
Verified
Journal Article
Closed access
SMSoumyadeep Mukherjee
Soumyadeep Mukherjee
DBDhrubajyoti Bairagya
Dhrubajyoti Bairagya
AKArpita Kar
Arpita Kar
PPParamita Paul
Paramita Paul
SBSubhasis Barik
Subhasis Barik